Skip to main content

Home/ Cerebral Palsy/ Group items tagged GERD treatment in infants

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
Lee Vander Loop

Safety and Efficacy Study of Axid Use in Infants Suffering From Gastroesophageal Reflux... - 0 views

www.clinicaltrials.gov/...NCT00373334

gastroesophageal reflux clinical trial clinical trials gastroesophageal reflux disease reflux in infants pediatric reflux GERD and infants GERD reflux

shared by Lee Vander Loop on 06 May 10 - Cached
  • Lee Vander Loop on 06 May 10
     
    Study conducted and completed to evaluate the efficacy, acceptability, and safety of Axid Oral Solution versus placebo in the treatment of gastroesophageal reflux disease (GERD) in infants age 30 days up to 1 year.
Lee Vander Loop

Medical Treatment for Gastroesophageal Reflux Disease (GERD) in Preterm Infants - 0 views

www.clinicaltrials.gov/...NCT00131248

clinical trial clinical trials gastroesophageal reflux GERD and premature infants GERD inducted bradycardia and apnea GERD treatment in infants research study reflux GERD

shared by Lee Vander Loop on 14 May 10 - Cached
  • Lee Vander Loop on 14 May 10
     
    Study Question: In premature infants with apnea and/or bradycardia attributed to gastroesophageal reflux disease (GERD), does treatment with medications (acid blockers and motility agents), compared to placebo, reduce the frequency of apnea and bradycardia?"
Lee Vander Loop

Safety and Efficacy Study of Axid Use in Infants Suffering From Gastroesophageal Reflux... - 0 views

www.clinicaltrials.gov/...NCT00373334

clinical trial clinical trials gastroesophageal reflux GERD treatment in infants Axid for GERD treatment in infants research study reflux GERD

shared by Lee Vander Loop on 14 May 10 - Cached
  • Lee Vander Loop on 14 May 10
     
    Study is to evaluate the efficacy, acceptability, and safety of Axid Oral Solution versus placebo in the treatment of gastroesophageal reflux disease (GERD) in infants age 30 days up to 1 year.
Lee Vander Loop

Study Evaluating the Efficacy and Safety of Pantoprazole in Infants With Symptomatic Ga... - 0 views

www.clinicaltrials.gov/...NCT00365300

gastroesophageal reflux disease gastroesophageal reflux clinical trials antacids and neonates GERD reflux PPI Pantoprazole

shared by Lee Vander Loop on 06 May 10 - Cached
  • Lee Vander Loop on 06 May 10
     
    Study to assess the efficacy of pantoprazole for the treatment of infants with symptomatic Gastroesophageal Reflux Disease (GERD)
Lee Vander Loop

A Pharmacokinetics (Blood Levels), Pharmacodynamics (How the Drug Acts on the Body) and... - 0 views

www.clinicaltrials.gov/...NCT00855361

gastroesophageal reflux disease gastroesophageal reflux antacids and neonates clinical trials safety reflux GERD antacids PPI pharmacokinetics Rabeprazole

shared by Lee Vander Loop on 06 May 10 - Cached
  • Lee Vander Loop on 06 May 10
     
    Study is to evaluate the pharmacokinetics (blood levels), pharmacodynamics (how the drug acts on the body), and the safety of rabeprazole sodium for the treatment of gastroesophageal reflux disease (GERD) in new borns and pre-term infants (less than 44 weeks of age).
Lee Vander Loop

To Evaluate the Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Ero... - 0 views

www.clinicaltrials.gov/...NCT00992589

gastroesophageal reflux clinical trial clinical trials gastroesophageal reflux disease protein pump inhibitor reflux GERD study Rabeprazole PPI

shared by Lee Vander Loop on 06 May 10 - Cached
  • Lee Vander Loop on 06 May 10
     
    Purpose of this study is to assess the effectiveness and safety of rabeprazole sodium, an inhibitor of gastric acid secretion of the protein pump inhibitor (PPI) class, compared with placebo in the treatment of gastrointestinal esophageal reflux disease (GERD) in infants 1 to 11 months of age.
1 - 6 of 6
Showing 20▼ items per page